These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Head and neck manifestations of distant carcinomas. Vega LG; Dipasquale J; Gutta R Oral Maxillofac Surg Clin North Am; 2008 Nov; 20(4):609-23. PubMed ID: 18940627 [TBL] [Abstract][Full Text] [Related]
8. Procollagen type 1 amino-terminal propeptide: a marker for bone metastases in prostate carcinoma. Klepzig M; Jonas D; Oremek GM Anticancer Res; 2009 Feb; 29(2):671-3. PubMed ID: 19331219 [TBL] [Abstract][Full Text] [Related]
9. Metastatic tumors to the oral and maxillofacial region: a retrospective study of 19 cases in West China and review of the Chinese and English literature. Shen ML; Kang J; Wen YL; Ying WM; Yi J; Hua CG; Tang XF; Wen YM J Oral Maxillofac Surg; 2009 Apr; 67(4):718-37. PubMed ID: 19304027 [TBL] [Abstract][Full Text] [Related]
10. Expression of macrophage inhibitory cytokine-1 in prostate cancer bone metastases induces osteoclast activation and weight loss. Wakchoure S; Swain TM; Hentunen TA; Bauskin AR; Brown DA; Breit SN; Vuopala KS; Harris KW; Selander KS Prostate; 2009 May; 69(6):652-61. PubMed ID: 19152406 [TBL] [Abstract][Full Text] [Related]
11. Midline shift, seizures and acute neurological deterioration due to cranial vault metastases from prostatic carcinoma. Weerakkody YD; Feltham RL; Leigh AJ J Clin Neurosci; 2009 Nov; 16(11):1506-7. PubMed ID: 19651516 [TBL] [Abstract][Full Text] [Related]
12. Clinical efficacy and safety of zoledronic acid in prostate and breast cancer. Doggrell SA Expert Rev Anticancer Ther; 2009 Sep; 9(9):1211-8. PubMed ID: 19761424 [TBL] [Abstract][Full Text] [Related]
13. Predictors of clinical metastasis in prostate cancer patients receiving androgen deprivation therapy: results from CaPSURE. Abouassaly R; Paciorek A; Ryan CJ; Carroll PR; Klein EA Cancer; 2009 Oct; 115(19):4470-6. PubMed ID: 19637339 [TBL] [Abstract][Full Text] [Related]
14. Fascin regulates prostate cancer cell invasion and is associated with metastasis and biochemical failure in prostate cancer. Darnel AD; Behmoaram E; Vollmer RT; Corcos J; Bijian K; Sircar K; Su J; Jiao J; Alaoui-Jamali MA; Bismar TA Clin Cancer Res; 2009 Feb; 15(4):1376-83. PubMed ID: 19228738 [TBL] [Abstract][Full Text] [Related]
15. Lymphoepithelioma-like carcinoma of the prostate. Lopez-Beltran A; Cheng L; Prieto R; Blanca A; Montironi R Hum Pathol; 2009 Jul; 40(7):982-7. PubMed ID: 19269013 [TBL] [Abstract][Full Text] [Related]
16. Urothelial and incidental prostate carcinoma in prostates from cystoprostatectomies for bladder cancer: is there a relationship between urothelial and prostate cancer? Barbisan F; Mazzucchelli R; Scarpelli M; Lopez-Beltran A; Cheng L; Kirkali Z; Montironi R BJU Int; 2009 Apr; 103(8):1058-63. PubMed ID: 19076141 [TBL] [Abstract][Full Text] [Related]
17. Proliferation of immature tumor vessels is a novel marker of clinical progression in prostate cancer. Gravdal K; Halvorsen OJ; Haukaas SA; Akslen LA Cancer Res; 2009 Jun; 69(11):4708-15. PubMed ID: 19487287 [TBL] [Abstract][Full Text] [Related]